Membership
Tour
Register
Log in
Juergen STEFFGEN
Follow
Person
Ulm, DE
People
Overview
Industries
Organizations
People
Information
Impact
Patents Applications
last 30 patents
Information
Patent Application
USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF INFLAMMATORY CONDITIONS
Publication number
20240317875
Publication date
Sep 26, 2024
Boehringer Ingelheim International GmbH
Fenglei HUANG
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ANTI-CD40 ANTIBODIES FOR USE IN TREATING AUTOIMMUNE DISEASE
Publication number
20240309105
Publication date
Sep 19, 2024
Boehringer Ingelheim International GmbH
Juergen Theodor STEFFGEN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
Publication number
20230265203
Publication date
Aug 24, 2023
Boehringer Ingelheim International GmbH
Scott Ronald BRODEUR
C07 - ORGANIC CHEMISTRY
Information
Patent Application
USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF INFLAMMATORY CONDITIONS
Publication number
20220089759
Publication date
Mar 24, 2022
Boehringer Ingelheim International GmbH
Fenglei HUANG
C07 - ORGANIC CHEMISTRY
Information
Patent Application
ANTI-CD40 ANTIBODIES FOR USE IN TREATING AUTOIMMUNE DISEASE
Publication number
20210261678
Publication date
Aug 26, 2021
Boehringer Ingelheim International GmbH
Juergen Theodor STEFFGEN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
Publication number
20190177420
Publication date
Jun 13, 2019
Boehringer Ingelheim International GmbH
Scott Ronald Brodeur
C07 - ORGANIC CHEMISTRY
Information
Patent Application
USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
Publication number
20170058038
Publication date
Mar 2, 2017
Boehringer Ingelheim International GmbH
Scott Ronald BRODEUR
C07 - ORGANIC CHEMISTRY